NCT01422213View on ClinicalTrials.gov

Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

598

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2013

Conditions

Major Depressive Disorder

Interventions

DRUG

Placebo

capsules; daily; orally

DRUG

Vortioxetine (Lu AA21004)

encapsulated tablets; daily; orally

DRUG

Vortioxetine (Lu AA21004)

encapsulated tablets; daily; orally

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT01422213 - Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter